logo
‘Dementia is just one part of who they are. My husband's underlying personality hasn't really changed'

‘Dementia is just one part of who they are. My husband's underlying personality hasn't really changed'

Irish Times20-05-2025
Nuala and Gerry Paley first met when she was 21 and he was 23. Their relationship didn't take off properly in the beginning, but they met again eight years later and were married within six months.
The couple, now aged 69 and 71, are living with the difficulty of early-onset
Alzheimer's
as Gerry was diagnosed with it in 2017, when he was just 63.
'I first saw changes in Gerry about a year before his diagnosis,' says Nuala. 'I noticed a change in his mood, and in his outlook on things. He was repeating himself, and seemed less aware of what he was talking about and what he was saying. The changes were subtle, but they were there. At that stage I had lived with him for 30 years, and when you're with someone that long, you notice these things.
'He was diagnosed in 2017 and now, some days it can be difficult to get him out of bed. Although he washes and dresses himself, I have to remind him to change, and I leave everything out for him and remind him constantly to move on to the next thing – for example, if he puts something into the microwave, he will think that he has eaten, so I will have to remind him.
READ MORE
'Mornings are busy generally, as he has several activities which I drive him to, and he loves walking our dog, Teddy, in the afternoon. He has the same route every day, and always ends up in the local cafe for a coffee, but, after that, the days can be long. Dementia brings many challenges, as anyone dealing with the condition will know and it is getting more stressful as Gerry's memory problems become more persistent.
'I have had my own medical issues over the past while, so it's very hard to keep up at times. It can be like Groundhog Day, every day, and the stress can be intense. I have wonderful friends, but I am very aware they have their own lives too.'
But despite the issues the Wicklow couple face on a daily basis, they have a strong relationship. Nuala says the most important thing for carers to do is to take any support offered, as some days are very difficult.
'We love each other, so it's very important to see the person beyond the condition,' she says. 'Dementia is just one part of who they are and Gerry's underlying personality hasn't really changed. He is very sociable, and loves being with other people. He is a very caring and kind person and is always looking out for others – he still has these characteristics.
'Of course, he might not realise that he has spoken to you about the same thing multiple times – but that's just something I have to accept, especially as what he says can be very wise. My advice to other carers is to talk, talk, talk – to whoever can offer help, information and support. I would encourage them to enrol in a carer's course, join support groups and get in touch with the
Alzheimer Society of Ireland
(ASI) to learn more about their services and supports.
'Gerry and I avail of the ASI's Day Care at Home Service and, twice a week, Lorna from the ASI comes to spend time with Gerry. They have the chats, play board games, go for walks with Teddy or grab a coffee. This gives me a break and takes away some of my stress; it makes a huge difference to our lives.'
Women over the age of 60 are twice as likely to develop Alzheimer's disease as they are to develop breast cancer during their lifetime

Report by Alzheimer's Research UK
Gerry and Nuala became members of the
Irish Dementia Working Group
and the Dementia Carers Campaign Network, advocacy groups that help to raise awareness of issues affecting people and families coping with dementia in Ireland. 'Our advocacy work has been incredibly rewarding – knowing that we are helping to ensure that the voices of people with dementia and their carers and families are heard,' says Nuala. 'Connecting with others who are in similar situations – whether they are caring for a loved one with dementia or living with the condition themselves – it gives you a sense of comfort and strength. Dementia affects so many families across the country, and Gerry and I want people like us to know that they are not alone.
'We need to stand back and admit we are only human and can only take so much – and we need huge supports to keep going day to day.'
Gerry and Nuala Paley. Photograph: Karen Morgan
Although dementia affects people of varying ages, Dr Laura O'Philbin, research and policy manager at the Alzheimer Society of Ireland says that women are much more likely to be affected by the condition, as figures show that women account for almost two-thirds of people living with dementia.
'A report by Alzheimer's Research UK published in 2022 highlighted that women over the age of 60 were twice as likely to develop Alzheimer's disease as they are to develop breast cancer during their lifetime,' she says. 'Women also play a significant role in caregiving, with approximately two-thirds of primary caregivers for people with dementia being female – this is supported by Irish census data. And as well as more often providing care, women tend to provide more intense levels of care and, in some cases, experience greater stigma and reduced social support compared to male caregivers.'
[
The year of hope: 'Exciting' advances achieved in search to reverse Alzheimer's disease
Opens in new window
]
In addition to this, Dr O'Philbin says women living with dementia may encounter unique challenges, including the compounded effects of ageism, sexism and ableism. 'These intersecting stigmas can result in social isolation and barriers to care. Traditional gender roles further complicate matters, as women are often seen as caregivers rather than care recipients, which can heighten feelings of guilt or inadequacy following a dementia diagnosis.
'This is a double-edged sword because, at the same time, the societal expectation for women to take on caregiving responsibilities, combined with limited recognition of caregiving as a valued role, has contributed to challenges for male caregivers. Some men report stigma which can lead to a reluctance in asking for or accepting help.'
About Dementia
According to the Alzheimer Society of Ireland, there are an estimated 64,000 people with dementia in Ireland.
The number of people with the condition is expected to reach 150,000 by 2045.
Globally, women account for about two-thirds of people living with dementia. This disparity is likely due to a combination of biological, genetic and social factors.
Ongoing research suggests that hormonal changes post-menopause and genetic risk factors, such as the APOE4 gene, contribute to the higher prevalence of dementia among women.
Although men and women are equally likely to carry the APOE4 gene, its association with dementia risk appears stronger in women, though the underlying reasons for this difference are not fully understood. Women's longer life expectancy also increases their likelihood of developing age-related conditions such as dementia.
Often, the early signs of dementia may be difficult to detect. Some people experience changes in their short-term memory early on, for others changes to mood or to language may be the early signs. Each person's experience with dementia is unique.
In general, early signs and symptoms can include:
Memory loss, particularly for recent events
Problems with language; difficulty finding the right word
Changes in mood and behaviour
Becoming confused in familiar surroundings or situations
Difficulty in following conversations, TV programmes or reading
Difficulty managing money and everyday tasks
Difficulty solving problems or doing puzzles
Loss of interest in hobbies and pastimes, lack of initiative to start something or go somewhere.
Repeating a question or story several times without realising
If you are experiencing any of these symptoms, it is advisable to make an appointment with your GP to discuss or contact the ASI's National and Free Confidential Helpline at 1800-341341 or
alzheimer.ie
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Cats develop dementia similarly to humans
Cats develop dementia similarly to humans

Irish Examiner

time12-08-2025

  • Irish Examiner

Cats develop dementia similarly to humans

Cats develop dementia similarly to humans with Alzheimer's disease, leading to hopes of a breakthrough in research, according to scientists. Experts at the University of Edinburgh carried out a post-mortem brain examination on 25 cats which exhibited symptoms of dementia in life, including confusion, sleep disruption and an increase in vocalisation, in a bid to explore new treatments for humans. Previously, researchers have studied genetically modified rodents, although the species does not naturally suffer from dementia. In feline dementia brains, a build-up was found of amyloid-beta, a toxic protein and one of the defining features of Alzheimer's disease, leading to hopes of a 'wonderful' breakthrough due to increased accuracy. Our findings highlight the striking similarities between feline dementia and Alzheimer's disease in people The breakthrough was hailed as a 'perfect natural model for Alzheimer's' by scientists who worked on it. Microscopy images revealed a build-up of amyloid-beta within synapses of older cats and feline dementia, and scientists hope the findings offer a clearer idea of how amyloid-beta may lead to feline cognitive dysfunction and memory loss, offering a valuable model for studying dementia in people. Synapses allow the flow of messages between brain cells, and losing these causes reduced memory and thinking abilities in humans with Alzheimer's. Researchers found evidence that brain support cells, astrocytes and microglia, engulfed the affected synapses, known as synaptic pruning, an important process during brain development but which contributes to dementia. Experts believe the findings could contribute to the development of new treatments for Alzheimer's disease, as well as help to understand and manage feline dementia. Previously, scientists studying Alzheimer's relied on genetically modified rodent models. However, studying feline dementia has the potential to help develop human treatments, due to increased accuracy, it is hoped. The study, funded by Wellcome and the UK Dementia Research Institute, is published in the European Journal of Neuroscience, and included scientists from the Universities of Edinburgh and California, UK Dementia Research Institute and Scottish Brain Sciences. Dr Robert McGeachan, study lead from the University of Edinburgh's Royal (Dick) School of Veterinary Studies, said: 'Dementia is a devastating disease — whether it affects humans, cats, or dogs. Our findings highlight the striking similarities between feline dementia and Alzheimer's disease in people. Feline dementia is the perfect natural model for Alzheimer's 'This opens the door to exploring whether promising new treatments for human Alzheimer's disease could also help our ageing pets. 'Because cats naturally develop these brain changes, they may also offer a more accurate model of the disease than traditional laboratory animals, ultimately benefiting both species and their caregivers.' Professor Danielle Gunn-Moore, personal chair of Feline Medicine at the Royal (Dick) School of Veterinary Studies, said: 'Feline dementia is so distressing for the cat and for its person. 'It is by undertaking studies like this that we will understand how best to treat them. This will be wonderful for the cats, their owners, people with Alzheimer's and their loved ones. 'Feline dementia is the perfect natural model for Alzheimer's — everyone benefits.'

Exercise and socialising can help people at risk of dementia, large-scale study finds
Exercise and socialising can help people at risk of dementia, large-scale study finds

Irish Times

time04-08-2025

  • Irish Times

Exercise and socialising can help people at risk of dementia, large-scale study finds

A combination of healthy activities including exercise , nutritious diet, computer brain games and socialising can improve cognitive performance in people at risk for dementia , according to a large new US study. The study, conducted in five locations across the US over two years, is the biggest randomised trial to examine whether healthy behaviours protect brain health. 'It confirms that paying attention to things like physical activity and vascular risk factors and diet are all really important ways to maintain brain health,' said Dr Kristine Yaffe, an expert in cognitive ageing at the University of California, San Francisco, who was not involved in the study. The results were presented laste week at the Alzheimer's Association International Conference in Toronto and published in the journal JAMA. READ MORE The study involved 2,111 people, aged 60 to 79, from diverse racial and ethnic backgrounds. None were cognitively impaired. All had sedentary lifestyles, suboptimal diets and two other dementia risk factors, such as a family history of cognitive decline and high blood pressure. [ Alzheimer's: 'I've lost my friend and my companion,' says Úna Crawford O'Brien of fellow Fair City actor Bryan Murray Opens in new window ] Half of the participants followed a structured programme. They were prescribed a healthy diet, socially engaging activities, and a weekly regimen of eight exercise sessions and three sessions of computerised cognitive training. They attended 38 meetings with facilitators and fellow participants. The study is the biggest randomised trial to examine whether healthy behaviours protect brain health. Photograph: Getty Images The other participants followed a self-guided programme. They were given educational materials and resources, and were regularly encouraged to engage in healthy behaviours. They attended six team meetings during the study. Cognitive scores for both groups improved considerably, with the high-intensity group improving somewhat more than the other group. 'The structured intervention had an extra benefit over and above the self-guided,' said Laura Baker, a professor of gerontology, geriatrics and internal medicine at Wake Forest University School of Medicine and a principal investigator of the study. Still, the study left many questions unanswered. We should have more aggressive targeting of interventions for people who have lower cognition, who are more at risk, and less intense or less expensive interventions for those with higher cognition — Kaarin Anstey Dr Lon Schneider, an Alzheimer's expert at the University of Southern California and a member of the Lancet Commission on dementia prevention, was impressed that 'both groups improved quite significantly'. But he noted that the difference in performance between the high-intensity and self-guided groups was 'very small', raising questions about how beneficial an intensive programme truly was. It was also unclear how much of the cognitive improvement reflected a 'practice effect', a common phenomenon whereby participants learn to do better on assessments simply by taking them several times, Schneider and other experts said. 'This does not demonstrate that any of the lifestyle changes in and of themselves, or the combination of them, is responsible for this level of improvement,' Schneider said. 'Or that it is necessarily related to neurodegeneration or Alzheimer's disease.' The results cannot be compared with the general population, as the study did not include a group that received no intervention. 'We didn't believe that it was ethical' to have a 'group that would not get anything', said Heather M Snyder, senior vice-president for medical and scientific relations at the Alzheimer's Association, which spent $50 million as the lead funder of the study. [ Irish study to assess dementia risk from sports-related brain injury in 360 retired athletes Opens in new window ] Baker said that even if the structured intervention was only modestly more effective than the self-guided one, 'I don't think we can say a small difference for an at-risk group is not meaningful.' She estimated that, compared with the self-guided group, the structured intervention 'slowed the cognitive ageing clock by one to two years', which might 'increase resilience against cognitive decline'. But several outside experts said that estimating any real-world advantage was difficult. They also questioned whether many people could realistically adopt an intense programme. [ Dementia diagnosis 'a very lonely experience at first': advocacy group calls for counselling support Opens in new window ] 'One of the big questions is how much do you need to do, and what's cost-effective,' said Kaarin Anstey, director of the Ageing Futures Institute at the University of New South Wales in Australia. 'If we only have very intensive interventions only a few people can afford, that's not actually going to address the bigger issue of population ageing and lots of people developing cognitive impairment.' The study, called US POINTER, was modelled after the first large randomised trial of lifestyle changes, called FINGER and conducted in Finland a dozen years ago. That study's intensive group showed 25 per cent greater cognitive improvement than a group receiving minimal intervention. The goal was to 'see if it can work' in a more diverse nation with different health and lifestyle issues, Baker said. The participants lived in North Carolina, Rhode Island, northern California, Houston and Chicago. More than two-thirds were women and 31 per cent were from racial or ethnic minority groups. Most had first-degree relatives with memory loss, and 30 per cent had the APOE4 gene mutation, which increases Alzheimer's risk. All of those subgroups experienced the same degree of cognitive improvement. Most people participated for the full two years, an indication that they were highly motivated whether or not they received intensive supervision. The study found that participants who started with lower cognitive scores benefited more. Photograph: Getty Images Phyllis Jones (66) of Aurora, Illinois, enrolled partly because her mother and grandmother had suffered from vascular dementia. Before the study, she said, stress from being laid off from a software engineering position and other job difficulties sent her to the emergency room with blurry vision and a racing heart. 'I was in really bad shape,' Jones said. Participating in the structured intervention 'woke me up'. At first, just 10 minutes of aerobics was exhausting, but she now exercises daily and has lost 30lb, she said. Buoyed by social support from the peer meetings, she found a new job as a software tester. She befriended another participant, Patty Kelly (81). They encouraged each other, and Kelly overhauled her own diet, sharply limiting sweets, cheese and fried food. Both women perceived some cognitive benefit, although they have not been told their scores. Jones felt more able to plan home projects and follow messaging chains at work. Kelly, who retired from a non-profit serving homeless families, said her driving had improved. 'I don't run into the side of the garage any more,' she said. The computer brain games were 'the hardest thing for us to get on board with', Jones said. That was true for other participants, too, Baker said. 'Is it practical to expect people to do this day after day?' Baker said about computerised brain training. 'Based on our experience, I'm going to say no.' But she said that any kind of intellectual stimulation could be helpful. [ Mobility issues? Here is a short workout you can do in a chair Opens in new window ] Since the trial ended last year, Jones has maintained many practices, she said, but found herself backsliding with sugar, and her cholesterol climbed. 'I think the structure is important, the accountability,' she said. The study found that participants who started with lower cognitive scores benefited more. It is unclear why, Anstey said, but could suggest that 'we should have more aggressive targeting of interventions for people who have lower cognition, who are more at risk, and less intense or less expensive interventions for those with higher cognition'. For both groups, the biggest cognitive improvement involved executive function – skills like planning and organising. Memory initially improved in both groups, but then declined, with no significant difference in the groups' ultimate memory scores. Memory loss is a core Alzheimer's symptom, Yaffe noted, so cognitive improvements in the trial were likely 'less related to Alzheimer's disease and more related to vascular changes in the brain'. The researchers will analyse blood, brain scans and other data to see if the activities spurred brain changes, reductions in Alzheimer's-related proteins or other biological factors, Snyder said. The US Alzheimer's Association will spend $40 million to follow the participants and help communities adopt locally tailored programmes. 'We now need to translate this and to turn brain health interventions into public health outcomes and solutions,' Snyder said. – This article originally appeared in The New York Times .

‘Game-changing' new drug could slow progression of Alzheimer's disease, research shows
‘Game-changing' new drug could slow progression of Alzheimer's disease, research shows

Irish Independent

time30-07-2025

  • Irish Independent

‘Game-changing' new drug could slow progression of Alzheimer's disease, research shows

There is currently no cure for the disease, which can severely affect memory and impact people's ability to carry out daily tasks. But a new drug called Trontinemab is showing promising results, the Alzheimer's Association International Conference in Toronto, was told. The drug has been tested on a small number of patients, but 49 out of 54 with early-stage Alzheimer's showed signs of improvement within 28 weeks during a trial, according to Roche, the pharmaceutical company behind the drug. Researchers said 91pc of the participants showed a reduction in clusters of protein on their brains, known as amyloid plaques – a key marker of Alzheimer's. The new drug was found to reduce amyloid proteins to a level so low that scan results on patients taking it for seven months were considered to be 'amyloid negative'. It is thought that the clearance of plaques slows down the progression of the disease and delays the onset of symptoms. Professor John Hardy of University College London's Institute of Neurology, who was not involved in the trial said the drug was a 'massive improvement'. 'There is no doubt this could be game-changing. We hope that if we can use these drugs on people early, we can halt the progression of disease, even before people have symptoms,' he said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store